- Home
- HOTH
as 07-26-2024 4:00pm EST
Hoth Therapeutics Inc is a development-stage biopharmaceutical company. It is focused on targeted therapeutics for patients suffering from conditions such as atopic dermatitis, also known as eczema, chronic wounds, psoriasis, asthma, and acne. The company owns the BioLexa Platform which combines an FDA-approved zinc chelator with one or more approved antibiotics in a topical dosage form to address unchecked eczema flare-ups.
| Founded: | 2017 | Country: | United States |
| Employees: | N/A | City: | NEW YORK |
| Market Cap: | 4.3M | IPO Year: | 2019 |
| Target Price: | $6.17 | AVG Volume (30 days): | 2.0M |
| Analyst Decision: | Strong Buy | Number of Analysts: | 3 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -1.94 | EPS Growth: | N/A |
| 52 Week Low/High: | $0.72 - $3.37 | Next Earning Date: | 08-12-2024 |
| Revenue: | N/A | Revenue Growth: | N/A |
| Revenue Growth (this year): | N/A | Revenue Growth (next year): | N/A |
Latest Hoth Therapeutics Inc. News
HOTH Breaking Stock News: Dive into HOTH Ticker-Specific Updates for Smart Investing
MT Newswires
2 days ago
Top Midday Gainers
PR Newswire
3 days ago
Hoth Therapeutics Partners with LTS Therapy Systems to Accelerate Novel Alzheimer's Treatment
PR Newswire
10 days ago
Hoth Therapeutics Expands Clinical Trial for Cancer Patients
PR Newswire
2 months ago
Hoth Therapeutics Announces Joint Development Agreement with Wise Systems International SRL to Utilize Artificial Intelligence for Drug Discovery
PR Newswire
3 months ago
Hoth Therapeutics to Attend EF Hutton Annual Global Conference, May 15, 2024
PR Newswire
4 months ago
Hoth Therapeutics Announces Exercise of Warrants for $4.2 Million Gross Proceeds
PR Newswire
4 months ago
Hoth Therapeutics' Wholly Owned Subsidiary Merveille.ai, Advances AI-Driven Discovery for Obesity Treatment
Zacks
4 months ago
Hoth Therapeutics (HOTH) Up on Upbeat Alzheimer's Drug Data
Compare HOTH vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "HOTH Hoth Therapeutics Inc. - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.